₹1,560.70
+4.20%NSE close, 16 Nov 2026
+249.70%
Venus Remedies is a small cap company, listed on NSE under the symbol VENUSREM. At ₹1,560.70 a share, the market values the whole company at ₹2,086 crore.
In FY26, it reported sales of ₹770 crore and a net profit of ₹103 crore, an operating margin of 19.1%. Over the last three years, sales grew 8.7% a year and net profit grew 36.2% a year.
The market values the company at 17.1 times its profit over the last twelve months and 2.96 times its book value; its return on equity is 17.3% and it has almost no borrowings.
Promoters hold 41.76% of the shares. Foreign institutions hold 3.14%, and domestic institutions, mutual funds among them, 0.74%.
Over the past year the share price has risen 253.3%, and it is 23.7% below its 52-week high.
₹ crore. Consolidated figures.
Social Media Communication regarding special window for re-lodgement of transfer requests of physical shares of Venus Remedies Limited
The financial results for the period ended September 30, 2026.
Venus Remedies Secures Five Marketing Authorisations Across Four Key International Markets
Social Media Communication regarding special window for re-lodgement of transfer requests
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 143 | 195 | 109 | 167 | 177 | 195 | 132 | 193 | 180 | 259 | 179 | 219 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 131 | 176 | 97.4 | 163 | 159 | 166 | 122 | 162 | 143 | 196 | 145 | 176 |
| Operating profit | 12.0 | 19.5 | 11.3 | 4.9 | 18.4 | 29.0 | 10.1 | 31.0 | 37.5 | 63.4 | 34.2 | 42.5 |
| Operating margin | 8.4% | 10.0% | 10.4% | 2.9% | 10.4% | 14.9% | 7.7% | 16.1% | 20.8% | 24.4% | 19.1% | 19.4% |
| Other income | 2.4 | 3.9 | 1.6 | 10.6 | 2.0 | 6.8 | 8.7 | 1.7 | 2.5 | 5.0 | 2.6 | 0.5 |
| Interest | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Depreciation | 6.5 | 5.9 | 6.0 | 6.4 | 5.4 | 4.7 | 6.2 | 6.2 | 6.6 | 6.8 | 6.8 | 9.5 |
| Profit before tax | 7.8 | 17.5 | 6.9 | 9.1 | 24.9 | 31.0 | 12.6 | 26.5 | 33.5 | 61.6 | 30.0 | 33.5 |
| Tax | 0.9 | 7.0 | 5.6 | 5.6 | 5.3 | 7.1 | 3.0 | 6.4 | 7.9 | 14.1 | 7.1 | 7.8 |
| Net profit | 6.9 | 10.8 | 1.2 | 3.5 | 19.6 | 21.0 | 9.6 | 20.1 | 25.6 | 47.5 | 23.0 | 25.7 |
| EPS (₹) | 5.13 | 7.86 | 0.92 | 2.63 | 14.66 | 15.71 | 7.18 | 15.06 | 19.14 | 35.53 | 17.18 | 19.19 |
₹ crore, financial years to March.
| Line | FY19 S | FY20 | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Sales | 302 | 341 | 548 | 599 | 601 | 648 | 770 |
| Expenses | 268 | 301 | 494 | 537 | 542 | 584 | 622 |
| Operating profit | 34.3 | 40.8 | 53.8 | 62.1 | 59.7 | 63.5 | 147 |
| Operating margin | 11.4% | 12.0% | 9.8% | 10.4% | 9.9% | 9.8% | 19.1% |
| Other income | 4.5 | 5.3 | 19.6 | 8.3 | 11.6 | 21.0 | 12.6 |
| Interest | 25.2 | 13.3 | 13.0 | 0.5 | 0.2 | 0.1 | 0.0 |
| Depreciation | 33.0 | 32.0 | 35.3 | 33.5 | 26.4 | 22.5 | 25.7 |
| Profit before tax | −28.3 | −8.0 | 48.6 | 36.4 | 44.6 | 71.8 | 134 |
| Tax | −1.2 | 2.0 | −13.2 | −4.3 | 16.2 | 23.6 | 31.4 |
| Net profit | −27.1 | −10.0 | 61.8 | 40.7 | 28.8 | 45.3 | 103 |
| EPS (₹) | 21.97 | -8.10 | 50.04 | 30.86 | 21.31 | 33.90 | 76.89 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 41.0 | 86.5 | 156 | 26.3 |
| From investing | −16.6 | −76.3 | −182 | −18.7 |
| From financing | −9.5 | −1.0 | −3.1 | −14.6 |
| Spent on fixed assets | −13.7 | −9.6 | −37.7 | −25.9 |
| Free cash flow | 27.3 | 76.8 | 118 | 0.4 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net margin | -9.0% | -2.9% | 11.3% | 6.8% | 4.8% | 7.0% | 13.4% |
| Operating margin | 11.4% | 12.0% | 9.8% | 10.4% | 9.9% | 9.8% | 19.1% |
| Return on equity | – | – | – | – | 5.9% | 8.1% | 15.5% |
| Return on capital employed | – | – | – | – | 8.5% | 12.8% | 20.2% |
| Return on assets | – | – | – | – | 4.6% | 6.3% | 12.0% |
| Debt to equity | – | – | – | – | 0.08 | 0.00 | 0.00 |
| Interest coverage | -0.10 | 0.40 | 4.70 | 76.90 | 213.60 | 1,027.10 | 3,354.80 |
| Debt to assets | – | – | – | – | 0.07 | 0.00 | 0.00 |
| Current ratio | – | – | – | – | 4.53 | 3.31 | 2.44 |
| Quick ratio | – | – | – | – | 2.99 | 2.58 | 1.64 |
| Cash ratio | – | – | – | – | 0.62 | 0.42 | 0.16 |
| Asset turnover | – | – | – | – | 0.96 | 0.91 | 0.90 |
| Fixed asset turnover | – | – | – | – | 4.51 | 5.20 | 6.14 |
| Inventory turnover | – | – | – | – | 2.90 | 3.80 | 3.00 |
| Receivables turnover | – | – | – | – | 7.50 | 5.80 | 7.50 |
| Gross margin | – | – | – | – | 41.0% | 41.6% | 49.7% |
| Cash from operations to profit | – | – | – | 101.0% | – | 191.0% | 152.0% |
| Effective tax rate | – | – | – | – | 36.2% | 32.8% | 23.4% |
Intimation regarding change in Corporate Identification Number (CIN).
Social Media Post on awareness on transfer of physical shares
Voting Results and Scrutinizer's report. Earlier submitted file was not machine readable.
A copy Srutinizers report of Annual General Meeting held on August 20, 2026. Further, the company has informed the Exchange regarding voting results.
The Amendment to AOA/MOA of the company.
Appointment of Dr. (Mrs.) Savita Gupta as Non- Executive Independent Director of the company w.e.f. December 30, 2026.
Appointment of Dr. (Mrs.) Manu Chaudhary as Joint Managing Director of the company w.e.f. October 01, 2026.
Appointment of Dr. Gurminder Singh Bedi as Non- Executive Independent Director of the company w.e.f. May 26, 2026.
Appointment of Mr. Saransh Chaudhary as Executive Director of the company w.e.f. May 26, 2026.
Proceedings of Annual General Meeting held on August 20, 2026
Notice of Annual General Meeting to be held on August 20, 2026, Annual report 2025-26 is also enclosed herewith.